早期胃癌：流行病学临床表现诊断和分期.docxVIP

早期胃癌：流行病学、临床表现、诊断和分期  HYPERLINK /contents/zh-Hans/early-gastric-cancer-epidemiology-clinical-manifestations-diagnosis-and-staging/contributors Author HYPERLINK /contents/zh-Hans/early-gastric-cancer-epidemiology-clinical-manifestations-diagnosis-and-staging/contributors Douglas Morgan, MD, MPH  HYPERLINK /contents/zh-Hans/early-gastric-cancer-epidemiology-clinical-manifestations-diagnosis-and-staging/contributors Section Editors HYPERLINK /contents/zh-Hans/early-gastric-cancer-epidemiology-clinical-manifestations-diagnosis-and-staging/contributors Mark Feldman, MD, MACP, AGAF, FACG HYPERLINK /contents/zh-Hans/early-gastric-cancer-epidemiology-clinical-manifestations-diagnosis-and-staging/contributors Kenneth K Tanabe, MD  HYPERLINK /contents/zh-Hans/early-gastric-cancer-epidemiology-clinical-manifestations-diagnosis-and-staging/contributors Deputy Editors HYPERLINK /contents/zh-Hans/early-gastric-cancer-epidemiology-clinical-manifestations-diagnosis-and-staging/contributors Anne C Travis, MD, MSc, FACG, AGAF HYPERLINK /contents/zh-Hans/early-gastric-cancer-epidemiology-clinical-manifestations-diagnosis-and-staging/contributors Diane MF Savarese, MD  HYPERLINK /contents/zh-Hans/early-gastric-cancer-epidemiology-clinical-manifestations-diagnosis-and-staging/contributors 翻译 HYPERLINK /contents/zh-Hans/early-gastric-cancer-epidemiology-clinical-manifestations-diagnosis-and-staging/contributors 张静, 副主任医师 Disclosures:?Douglas Morgan, MD, MPH?Grant/Research/Clinical Trial Support: Cancer Prevention Pharmaceuticals [Gastric cancer prevention (Eflornithine)].?Mark Feldman, MD, MACP, AGAF, FACG?Nothing to disclose.?Kenneth K Tanabe, MD?Consultant/Advisory Boards: Astellas [hepatocellular carcinoma (enzalutamide)]. Patent Holder (no licenses/royalties to date): EGF SNP to determine risk for HCC (cirrhosis, hepatocellular carcinoma); Use of EGFR inhibitors to prevent HCC (cirrhosis, hepatocellular carcinoma).?Anne C Travis, MD, MSc, FACG, AGA